NCT00309387

Brief Summary

The Collaborative Italian-American Clinical Trial of Nutritional Supplements and Age-related Cataract (CTNS) is a 13-year study designed primarily to evaluate the safety and efficacy of a vitamin-mineral supplement (Centrum) containing recommended daily-allowance dosage (RDA) in preventing age-related cataract or delaying its progression in participants with early or no cataract at baseline.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,020

participants targeted

Target at P75+ for phase_3

Timeline
Completed

Started May 1995

Longer than P75 for phase_3

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 1995

Completed
10.9 years until next milestone

First Submitted

Initial submission to the registry

March 29, 2006

Completed
2 days until next milestone

First Posted

Study publicly available on registry

March 31, 2006

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2007

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2007

Completed
5 years until next milestone

Results Posted

Study results publicly available

April 24, 2012

Completed
Last Updated

May 6, 2013

Status Verified

April 1, 2013

Enrollment Period

12 years

First QC Date

March 29, 2006

Results QC Date

March 28, 2012

Last Update Submit

April 30, 2013

Conditions

Keywords

CataractNutritional supplements

Outcome Measures

Primary Outcomes (1)

  • Number of Participants Showing Development or Progression of Age-related Cataract or Undergoing Cataract Surgery During Follow-up

    number of participants in whom any of the following occur in at least one eligible eye during follow-up: cataract surgery; nuclear opacity: a 1.5 U increase in opalescence from baseline; cortical opacity: a 10% increase in area within a standard 5 mm circle area of the lens from baseline; posterior subcapsular opacity: a 5% increase in area within a standard 5 mm circle area of the lens from baseline.

    at yearly intervals from baseline for approximately ten years

Secondary Outcomes (5)

  • Number of Participants Showing Development or Progression of Nuclear Lens Opacities

    at yearly intervals from baseline for approximately ten years

  • Number of Participants Showing Development or Progression of Cortical Lens Opacities

    at yearly intervals from baseline for approximately ten years

  • Number of Participants Showing Development or Progression of Posterior Subcapsular Opacities

    at yearly intervals from baseline for approximately ten years

  • Number of Participants Undergoing Cataract Surgery

    at 6 month intervals from baseline for approximately 10 yrs

  • Number of Participants With a Decrease in Visual Acuity

    at 6 month intervals from baseline for approximately 10 yrs

Study Arms (2)

Centrum

EXPERIMENTAL

multivitamin-mineral supplement. RDA dosage. 1 tablet a day for the whole study duration.

Dietary Supplement: Centrum

placebo

PLACEBO COMPARATOR

placebo pills. One tablet a day for the whole study duration.

Other: Placebo

Interventions

CentrumDIETARY_SUPPLEMENT

Multivitamin/mineral supplement containing US RDA levels of nutrients. 1 tablet a day for the expected duration of follow-up (on average 10 yrs).

Centrum
PlaceboOTHER

placebo tablets manufactured to mimic Centrum tablets.

placebo

Eligibility Criteria

Age55 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Clinical and photographic diagnosis of early or no age-related cataract
  • Participants with early cataract must have at least one eligible eye with VA score 20/32 or better
  • Participants with no cataract must have VA score 20/32 or better in both eyes.

You may not qualify if:

  • Advanced cataract
  • Bilateral aphakia or pseudophakia
  • Any ocular disease or condition that might complicate the future evaluation of cataract
  • Regular use of nutritional supplements
  • Failure to take at least 75% of run-in medication
  • Cancer with evidence of recurrence in the past 5 years
  • Major cerebral or cardiovascular events in past 12 months
  • Current participation to other clinical trials
  • Any condition likely to prevent adherence to CTNS follow-up schedule

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dpt. Scienze Otorino-Odonto Oftalmologiche, University of Parma

Parma, 43100, Italy

Location

Related Publications (4)

  • CTNS Study Group. The Italian-American Clinical Trial of Nutritional Supplements and Age-Related Cataract (CTNS): design implications. CTNS report no. 1. Control Clin Trials. 2003 Dec;24(6):815-29. doi: 10.1016/s0197-2456(03)00095-3.

    PMID: 14662284BACKGROUND
  • Ferrigno L, Aldigeri R, Rosmini F, Sperduto RD, Maraini G; Italian-American Cataract Study Group. Associations between plasma levels of vitamins and cataract in the Italian-American Clinical Trial of Nutritional Supplements and Age-Related Cataract (CTNS): CTNS Report #2. Ophthalmic Epidemiol. 2005 Apr;12(2):71-80. doi: 10.1080/09286580590932815.

  • Clinical Trial of Nutritional Supplements and Age-Related Cataract Study Group; Maraini G, Williams SL, Sperduto RD, Ferris F, Milton RC, Clemons TE, Rosmini F, Ferrigno L. A randomized, double-masked, placebo-controlled clinical trial of multivitamin supplementation for age-related lens opacities. Clinical trial of nutritional supplements and age-related cataract report no. 3. Ophthalmology. 2008 Apr;115(4):599-607.e1. doi: 10.1016/j.ophtha.2008.01.005.

  • Maraini G, Williams SL, Sperduto RD, Ferris FL, Milton RC, Clemons TE, Rosmini F, Ferrigno L. Effects of multivitamin/mineral supplementation on plasma levels of nutrients. Report No. 4 of the Italian-American clinical trial of nutritional supplements and age-related cataract. Ann Ist Super Sanita. 2009;45(2):119-27.

MeSH Terms

Conditions

Cataract

Condition Hierarchy (Ancestors)

Lens DiseasesEye Diseases

Results Point of Contact

Title
Giovanni Maraini, MD
Organization
University of Parma

Study Officials

  • Giovanni Maraini, MD

    University of Parma

    STUDY CHAIR
  • Robert D Sperduto, MD

    National Eye Institute (NEI)

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
NIH
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 29, 2006

First Posted

March 31, 2006

Study Start

May 1, 1995

Primary Completion

May 1, 2007

Study Completion

May 1, 2007

Last Updated

May 6, 2013

Results First Posted

April 24, 2012

Record last verified: 2013-04

Locations